STAPHYLOCOCCUS AUREUS BACTEREMIA
Clinical trials for STAPHYLOCOCCUS AUREUS BACTEREMIA explained in plain language.
Never miss a new study
Get alerted when new STAPHYLOCOCCUS AUREUS BACTEREMIA trials appear
Sign up with your email to follow new studies for STAPHYLOCOCCUS AUREUS BACTEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough staph blood infections
Disease control CompletedThis study tested a new medicine called AP-SA02, given alongside standard antibiotics, for adults with a serious Staphylococcus aureus bloodstream infection. The main goal was to check if the combination is safe and tolerable. Fifty-six hospitalized adults took part, and research…
Matched conditions: STAPHYLOCOCCUS AUREUS BACTEREMIA
Phase: PHASE1, PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 07:57 UTC
-
New antibody shows promise against dangerous staph blood infections
Disease control CompletedThis study tested a new human antibody called 514G3 in 52 hospitalized patients with Staphylococcus aureus bloodstream infections. Participants received either a single dose of the antibody plus standard antibiotics or a placebo plus antibiotics. The goal was to check safety and …
Matched conditions: STAPHYLOCOCCUS AUREUS BACTEREMIA
Phase: PHASE1, PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Phone Check-Ins boost care for deadly blood infection
Knowledge-focused CompletedThis study tested whether giving doctors checklist-based phone call support could improve how they manage Staphylococcus aureus bloodstream infections. 124 adult hospital patients with a first-time infection took part. The goal was to see if the calls helped doctors follow treatm…
Matched conditions: STAPHYLOCOCCUS AUREUS BACTEREMIA
Phase: NA • Sponsor: University Medicine Greifswald • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC